Abu Dhabi: The world’s foremost graduate research university devoted exclusively to AI, Mohamed bin Zayed University of Artificial Intelligence (MBZUAI), is steadfast in its commitment to conducting groundbreaking research aimed at identifying and implementing solutions that drive progress in society.
On World Health Day, MBZUAI President and University Professor, Mr. Eric Xing, stated that, “AI has the potential to transform many aspects of healthcare, from the early detection and diagnosis of diseases, to enhanced monitoring and tracking of patients and the development of new treatments and personalised care.”
“MBZUAI is dedicated to developing AI for good, and some of the best use-cases are in healthcare. I am optimistic that research being conducted by MBZUAI at our campus, and in conjunction with organisations in other locations, will – within just a few years – lead to completely new ways of understanding and treating diseases, and better ways of organising our healthcare systems regionally and internationally,” the President further added.
In March 2023, MBZUAI and Infinite Brain Technologies (IBT) announced a five-year R&D partnership to establish a collaborative research laboratory. Their focus will be on leveraging the capabilities of AI technologies to create customised digital therapeutics for human brain health.
By combining the research strengths of IBT in the development and commercialisation of digital therapeutics, and the AI expertise of MBZUAI, the collaboration aims to create powerful and customised treatments for brain and mental disorders.
This endeavour is particularly significant considering the alarming statistics provided by the World Health Organization (WHO), which indicate that around one billion people worldwide, roughly one in eight individuals, are afflicted by some form of mental illness, ranging from depression and anxiety to schizophrenia. Achieving this personalised approach to mental health treatment would be a remarkable feat.